Biogen Idec announces collaboration with leading research institutions to sequence genomes of patients with ALS
17 July 2012 | By Biogen Idec
Labs at Duke University and HudsonAlpha Institute to lead research consortium...
List view / Grid view
News
GSK to acquire Human Genome Sciences for US$14.25 per share in cash
16 July 2012 | By GlaxoSmithKline
GSK to acquire full ownership of BENLYSTA®, albiglutide and darapladib...
AstraZeneca reports terms of David Brennan’s retirement
16 July 2012 | By AstraZeneca
AstraZeneca reported on the remuneration arrangements relating to David Brennan’s retirement...
GlaxoSmithKline celebrates its role in supporting the biggest anti-doping operation in the history of the Olympic Games
16 July 2012 | By GlaxoSmithKline
GSK launches new advertising campaign...
U.S. FDA approves Gilead ’s Truvada® for reducing the risk of acquiring HIV
16 July 2012 | By Gilead Sciences
The U.S. FDA has approved once-daily oral Truvada®...
Ilka Diester wins Boehringer Ingelheim’s FENS Award 2012 for Exceptional Research in Neuroscience
16 July 2012 | By Boehringer Ingelheim
This year's Boehringer Ingelheim FENS Award was granted to Ilka Diester...
The Abbott Fund announces $1 million partnership with the Secretary’s International Fund for Women and Girls
16 July 2012 | By Abbott
The Abbott Fund announces $1 million partnership...
Merck highlights data presentations at the Alzheimer’s Association International Conference 2012
13 July 2012 | By Merck
Merck announced presentations at the upcoming AAI Conference...
Abbott focuses on the importance of information management and automation at the AACC Lab Expo
Abbott will feature new solutions to improve data management and automation at this year’s American Association for Clinical Chemistry (AACC) annual meeting, July 15-19, in Los Angeles, Calif. Solutions to further enhance efficiency and workflow in today’s laboratories will be the focal point of the Abbott exhibit.
GSK and Theravance announce regulatory submissions for FF/VI in the US and Europe
13 July 2012 | By GlaxoSmithKline
Relvar™ and Breo™ proposed as brand names for FF/VI in EU and US...
Daiichi Sankyo to build production facilities for biopharmaceuticals
12 July 2012 | By Daiichi Sankyo
Daiichi Sankyo has been approved for the Japanese Ministry of Economy, Trade and Industry’s production facility building grant...
US Regulatory Update – Tykerb® (lapatinib)
12 July 2012 | By GlaxoSmithKline
GlaxoSmithKline has withdrawn a supplemental New Drug Application to the US FDA for Tykerb...
Update on Phase III trial for Odanacatib, Merck’s investigational cat-K inhibitor for Osteoporosis
11 July 2012 | By Merck
Merck announced an update on the Phase III trial...
GSK announces positive data from Harmony 8 and completion of clinical registration package for albiglutide
11 July 2012 | By GlaxoSmithKline
Data has been received from the Phase III Harmony 8 study...
Lilly announces Pomaglumetad Methionil did not meet primary endpoint of clinical study
11 July 2012 | By Eli Lilly and Company
Eli Lilly and Company announced negative clinical trial results...
